DuoStim: a new option for fertility preservation for a woman with Turner syndrome

References

• Sybert VP, McCauley E. Turner's syndrome. N Engl J Med. 2004;351(12):1227–1238.
   PubMed Web of Science ®Google Scholar
• Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab. 2010;95(4):1487–1495.
   PubMed Web of Science ®Google Scholar
• Hreinsson JG, Otala M, Fridström M, et al. Follicles are found in the ovaries of adolescent girls with Turner’s syndrome. J Clin Endocrinol Metab. 2002;87:3618–3623.
   PubMed Web of Science ®Google Scholar
• Cobo A, García-Velasco JA, Coello A, et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105(3):755–764.e8.
   PubMed Web of Science ®Google Scholar
• Sunkara SK, Rittenberg V, Raine-Fenning N, et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26(7):1768–1774.
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;77:G1–G70.
   Google Scholar
• Goldman KN, Noyes NL, Knopman JM, et al. Oocyte efficiency: Does live birth rate differ when analyzing cryopreserved and fresh oocytes on a per-oocyte basis?. Fertil Steril. 2013;100(3):712–717.
   PubMed Web of Science ®Google Scholar
• Ye M, Yeh J, Kosteria I, et al. Progress in fertility preservation strategies in Turner syndrome. Front Med. 2020;7:3.
   Web of Science ®Google Scholar
• Weenen C, Laven JS, Von Bergh AR, et al. Anti-Müllerian hormone expression pattern in the human ovary: Potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77–83.
   PubMed Web of Science ®Google Scholar
• Andersen CY, Schmidt KT, Kristensen SG, et al. Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles. Hum Reprod. 2010;25(5):1282–1287.
   PubMed Web of Science ®Google Scholar
• de Vet A, Laven JS, de Jong FH, et al. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357–362.
   PubMed Web of Science ®Google Scholar
• Seifer DB, MacLaughlin DT, Christian BP, et al. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77(3):468–471.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Schonäuer LM, Righini C, et al. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003;18(2):323–327.
   PubMed Web of Science ®Google Scholar
• Kavoussi SK, Fisseha S, Smith YR, et al. Oocyte cryopreservation in a woman with mosaic Turner syndrome- a case report. J Reprod Med. 2008;53:223–226.
   PubMed Web of Science ®Google Scholar
• Balen AH, Harris SE, Chambers EL, et al. Conservation of fertility and oocyte genetics in a young woman with mosaic Turner syndrome. BJOG. 2010;117(2):238–242.
   PubMed Web of Science ®Google Scholar
• Oktay K, Bedoschi G. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in turner syndrome or cancer treatments. J Pediatr Adolesc Gynecol. 2014;27(6):342–346.
   PubMed Web of Science ®Google Scholar
• Talaulikar VS, Conway GS, Pimblett A, et al. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome. Fertil Steril. 2019;111(3):505–509.
   PubMed Web of Science ®Google Scholar
• Vergier J, Bottin P, Saias J, et al. Fertility preservation in Turner syndrome: karyotype does not predict ovarian response to stimulation. Clin Endocrinol. 2019;91(5):646–651.
   PubMed Web of Science ®Google Scholar
• Lau NM, Huang JY, MacDonald S, et al. Feasibility of fertility preservation in young females with Turner syndrome. Reprod Biomed Online. 2009;18(2):290–295.
   PubMed Web of Science ®Google Scholar
• El-Shawarby SA, Sharif F, Conway G, et al. Oocyte cryopreservation after controlled ovarian hyperstimulation in mosaic Turner syndrome: another fertility preservation option in a dedicated UK clinic. BJOG. 2010;117(2):234–237.
   PubMed Web of Science ®Google Scholar
• Ubaldi FM, Capalbo A, Vaiarelli A, et al. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril. 2016;105(6):1488–1495.e1.
   PubMed Web of Science ®Google Scholar
• Jin B, Niu Z, Xu B, et al. Comparison of clinical outcomes among dual ovarian stimulation, mild stimulation and luteal phase stimulation protocols in women with poor ovarian response. Gynecol Endocrinol. 2018;34(8):694–697.
   PubMed Web of Science ®Google Scholar
• Vaiarelli A, Cimadomo D, Conforti A, et al. Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series. Fertil Steril. 2020;113(1):121–130.
   PubMed Web of Science ®Google Scholar
• Cakmak H, Katz A, Cedars MI, et al. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100(6):1673–1680.
   PubMed Web of Science ®Google Scholar
• Qin N, Chen Q, Hong Q, et al. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril. 2016;106(2):334–341.e1.
   PubMed Web of Science ®Google Scholar
• Kofinas JD, Mehr H, Ganguly N, et al. Is it the egg or the endometrium? Elevated progesterone on day of trigger is not associated with embryo ploidy nor decreased success rates in subsequent embryo transfer cycles. J Assist Reprod Genet. 2016;33(9):1169–1174.
   PubMed Web of Science ®Google Scholar
• Kuang Y, Chen Q, Fu Y, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62–70.e3.
   PubMed Web of Science ®Google Scholar
• Chen Q, Wang Y, Sun L, et al. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders. Reprod Biol Endocrinol. 2017;15(1):71.
   Google Scholar
• Xiao ZN, Peng JL, Yang J, et al. Flexible GnRH antagonist protocol versus progestin-primed ovarian stimulation (PPOS) protocol in patients with polycystic ovary syndrome: comparison of clinical outcomes and ovarian response. Curr Med Sci. 2019;39(3):431–436.
   PubMed Web of Science ®Google Scholar
• La Marca A, Capuzzo M. Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Reprod Biomed Online. 2019;39(2):321–331.
   PubMed Web of Science ®Google Scholar